iodine has been researched along with Nephrogenic Fibrosing Dermopathy in 5 studies
Iodine: A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.
diiodine : Molecule comprising two covalently bonded iodine atoms with overall zero charge..
Nephrogenic Fibrosing Dermopathy: A chronic, acquired, idiopathic, progressive eruption of the skin that occurs in the context of RENAL FAILURE. It is sometimes accompanied by systemic fibrosis. The pathogenesis seems to be multifactorial, with postulated involvement of circulating fibrocytes. There is a strong association between this disorder and the use of gadolinium-based contrast agents.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In patients with renal failure, iodinated contrast agents may cause acute deterioration of the renal function and gadolinium-based contrast agents (GBCAs) may cause nephrogenic systemic fibrosis (NSF)." | 4.87 | [Kidney and iodinated and gadolinium-based contrast agents]. ( Clément, O; Faye, N; Fournier, L; Frija, G; Siauve, N, 2011) |
| "To help establish consensus on the safe use of contrast media in Japan." | 1.43 | Safe use of iodinated and gadolinium-based contrast media in current practice in Japan: a questionnaire survey. ( Arai, Y; Awai, K; Fukuda, K; Hayakawa, K; Hayashi, H; Ishiguchi, T; Kanematsu, M; Korogi, Y; Kuwatsuru, R; Murakami, T; Narumi, Y; Sugimoto, H; Takagi, R; Takehara, Y; Tsushima, Y; Yoshimitsu, K, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benzon, HT | 1 |
| Liu, BP | 1 |
| Patel, A | 1 |
| Benzon, HA | 1 |
| Thomsen, HS | 1 |
| Tsushima, Y | 1 |
| Ishiguchi, T | 1 |
| Murakami, T | 1 |
| Hayashi, H | 1 |
| Hayakawa, K | 1 |
| Fukuda, K | 1 |
| Korogi, Y | 1 |
| Sugimoto, H | 1 |
| Takehara, Y | 1 |
| Narumi, Y | 1 |
| Arai, Y | 1 |
| Kuwatsuru, R | 1 |
| Yoshimitsu, K | 1 |
| Awai, K | 1 |
| Kanematsu, M | 1 |
| Takagi, R | 1 |
| Clément, O | 1 |
| Faye, N | 1 |
| Fournier, L | 1 |
| Siauve, N | 1 |
| Frija, G | 1 |
| Nyman, U | 1 |
| Elmståhl, B | 1 |
| Leander, P | 1 |
| Almén, T | 1 |
1 review available for iodine and Nephrogenic Fibrosing Dermopathy
| Article | Year |
|---|---|
[Kidney and iodinated and gadolinium-based contrast agents].
Topics: Aged; Contrast Media; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fluid T | 2011 |
4 other studies available for iodine and Nephrogenic Fibrosing Dermopathy
| Article | Year |
|---|---|
Caution in Using Gadolinium-Based Contrast Agents in Interventional Pain Procedures.
Topics: Brain; Chelating Agents; Contrast Media; Gadolinium; Histamine Antagonists; Humans; Iodine; Ligands; | 2018 |
Gadolinium- or iodine-based contrast media: which choice?
Topics: Contrast Media; Evidence-Based Medicine; Gadolinium; Humans; Iodine; Magnetic Resonance Imaging; Nep | 2014 |
Safe use of iodinated and gadolinium-based contrast media in current practice in Japan: a questionnaire survey.
Topics: Breast Feeding; Contrast Media; Female; Gadolinium; Humans; Iodine; Japan; Kidney Diseases; Kidney F | 2016 |
Iodine contrast media doses equal-attenuating with gadolinium chelates at CT-aortography may have less risk of contrast-induced nephropathy and no risk of nephrogenic systemic fibrosis in azotaemic patients!
Topics: Aortic Diseases; Aortography; Azotemia; Contrast Media; Creatinine; Dose-Response Relationship, Drug | 2008 |